Nestlé is launching a line of food products tailored to people using weight-loss medication in an effort to capitalize on a market expected to reach $30 billion in the next six years. Under its ...
Nestle plans to launch a frozen-foodbrand Vital Pursuit aimed at consumers who are taking Ozempic and Wegovy. GLP-1 drugs have taken off for weight loss and diabetes treatment, sparking ...
Some results have been hidden because they may be inaccessible to you